VanEck Biotech ETF

BBH
$204.78 -1.48 (-0.72%)
Dividend Yield 0.47%
Payout Frequency Yearly

Dividend History

Pay DateAmountEx-DateRecord Date
December 26, 2025$0.962025-12-222025-12-22
December 24, 2024$1.252024-12-232024-12-23
December 22, 2023$0.712023-12-182023-12-19
December 23, 2022$0.752022-12-192022-12-20
December 27, 2021$0.402021-12-202021-12-21

Dividends Summary

Company News

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
The Motley Fool • Sarah Sidlow • July 8, 2026

The article compares two healthcare ETFs: VanEck Biotech ETF (BBH) with 25 concentrated holdings and State Street SPDR S&P Pharmaceuticals ETF (XPH) with 65 diversified holdings. Both charge identical 0.35% expense ratios and offer 0.50% dividend yields, but XPH delivered significantly higher 1-year returns (64.30% vs 33.30%) and lower volatility...

Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
Benzinga • Vandana Singh • March 10, 2026

Vertex Pharmaceuticals shares surged 6.32% in premarket trading after announcing positive Phase 3 RAINIER trial results for its kidney drug povetacicept. The trial met its primary objective with a 52% reduction in urine protein and 49.8% reduction versus placebo. An analyst upgraded the probability of success to 90% ahead of expected FDA approval...

Biotech ETF (BBH) Hits New 52-Week High
Zacks Investment Research • Sanghamitra Saha • June 25, 2024

The biotech ETF BBH hit a 52-week high lately. Can it soar higher?

Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks Investment Research • Zacks Equity Research • June 17, 2024

Sector ETF report for BBH

Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks Investment Research • Zacks Equity Research • April 15, 2024

Sector ETF report for BBH

Related Companies